Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Ueda

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2009
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|December 8, 2017
The Relationship between Neurite Density Measured with Confocal Microscopy in a Cleared Mouse Brain and Metrics Obtained from Diffusion Tensor and Diffusion Kurtosis ImagingRyusuke Irie, Koji Kamagata, Aurelien Kerever, et al.
Nature Communications|April 23, 2020
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Nature Communications|December 19, 2019
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Insights Into Imaging|January 3, 2025
Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancerYuki Arita, Thomas C Kwee, Oguz Akin, et al.
Scientific Reports|April 1, 2024
Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disordersYuki Momota, Shogyoku Bun, Jinichi Hirano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2024
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related SchwannomatosisRyota Tamura, Yoshiharu Yamanobe, Masato Fujioka, et al.
Neurology. Genetics|January 15, 2025
<i>SLC9A6</i>-Linked Parkinson Syndrome in Female Heterozygotes Is Associated With PET-Detectable Tau PathologyYasuharu Yamamoto, Keisuke Takahata, Morinobu Seki, et al.
Alzheimer'S Research & Therapy|September 4, 2023
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid statusShogyoku Bun, Daisuke Ito, Toshiki Tezuka, et al.
Neurology|September 29, 2022
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient ManagementSho Shimohama, Toshiki Tezuka, Keisuke Takahata, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2009
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|December 8, 2017
The Relationship between Neurite Density Measured with Confocal Microscopy in a Cleared Mouse Brain and Metrics Obtained from Diffusion Tensor and Diffusion Kurtosis ImagingRyusuke Irie, Koji Kamagata, Aurelien Kerever, et al.
Nature Communications|April 23, 2020
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Nature Communications|December 19, 2019
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Insights Into Imaging|January 3, 2025
Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancerYuki Arita, Thomas C Kwee, Oguz Akin, et al.
Scientific Reports|April 1, 2024
Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disordersYuki Momota, Shogyoku Bun, Jinichi Hirano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2024
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related SchwannomatosisRyota Tamura, Yoshiharu Yamanobe, Masato Fujioka, et al.
Neurology. Genetics|January 15, 2025
<i>SLC9A6</i>-Linked Parkinson Syndrome in Female Heterozygotes Is Associated With PET-Detectable Tau PathologyYasuharu Yamamoto, Keisuke Takahata, Morinobu Seki, et al.
Alzheimer'S Research & Therapy|September 4, 2023
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid statusShogyoku Bun, Daisuke Ito, Toshiki Tezuka, et al.
Neurology|September 29, 2022
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient ManagementSho Shimohama, Toshiki Tezuka, Keisuke Takahata, et al.
Pageof 11